IMUC
Price
$0.10
Change
-$0.00 (-0.00%)
Updated
Jul 24 closing price
Capitalization
12.65M
ORMP
Price
$2.16
Change
-$0.08 (-3.57%)
Updated
Jul 25 closing price
Capitalization
88.23M
17 days until earnings call
Interact to see
Advertisement

IMUC vs ORMP

Header iconIMUC vs ORMP Comparison
Open Charts IMUC vs ORMPBanner chart's image
EOM Pharmaceutical Holdings
Price$0.10
Change-$0.00 (-0.00%)
Volume$2.15K
Capitalization12.65M
Oramed Pharmaceuticals
Price$2.16
Change-$0.08 (-3.57%)
Volume$37.72K
Capitalization88.23M
IMUC vs ORMP Comparison Chart in %
Loading...
IMUC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMUC vs. ORMP commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMUC is a StrongBuy and ORMP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (IMUC: $0.10 vs. ORMP: $2.24)
Brand notoriety: IMUC and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMUC: 103% vs. ORMP: 0%
Market capitalization -- IMUC: $12.65M vs. ORMP: $88.23M
IMUC [@Biotechnology] is valued at $12.65M. ORMP’s [@Biotechnology] market capitalization is $88.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMUC’s FA Score shows that 1 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • IMUC’s FA Score: 1 green, 4 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than IMUC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMUC’s TA Score shows that 4 TA indicator(s) are bullish while ORMP’s TA Score has 5 bullish TA indicator(s).

  • IMUC’s TA Score: 4 bullish, 3 bearish.
  • ORMP’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than IMUC.

Price Growth

IMUC (@Biotechnology) experienced а +25.00% price change this week, while ORMP (@Biotechnology) price change was +5.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

IMUC is expected to report earnings on Nov 20, 2024.

ORMP is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($88.2M) has a higher market cap than IMUC($12.7M). ORMP has higher P/E ratio than IMUC: ORMP (20.91) vs IMUC (0.02). ORMP YTD gains are higher at: -7.438 vs. IMUC (-40.758). IMUC has higher annual earnings (EBITDA): -5.65M vs. ORMP (-21.53M). ORMP has more cash in the bank: 131M vs. IMUC (85.3K). ORMP has higher revenues than IMUC: ORMP (2M) vs IMUC (0).
IMUCORMPIMUC / ORMP
Capitalization12.7M88.2M14%
EBITDA-5.65M-21.53M26%
Gain YTD-40.758-7.438548%
P/E Ratio0.0220.910%
Revenue02M-
Total Cash85.3K131M0%
Total DebtN/A301K-
FUNDAMENTALS RATINGS
IMUC vs ORMP: Fundamental Ratings
IMUC
ORMP
OUTLOOK RATING
1..100
3020
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
56
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10093
PRICE GROWTH RATING
1..100
8878
P/E GROWTH RATING
1..100
10050
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMUC's Valuation (9) in the Biotechnology industry is somewhat better than the same rating for ORMP (56) in the Pharmaceuticals Other industry. This means that IMUC’s stock grew somewhat faster than ORMP’s over the last 12 months.

IMUC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that IMUC’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's SMR Rating (93) in the Pharmaceuticals Other industry is in the same range as IMUC (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to IMUC’s over the last 12 months.

ORMP's Price Growth Rating (78) in the Pharmaceuticals Other industry is in the same range as IMUC (88) in the Biotechnology industry. This means that ORMP’s stock grew similarly to IMUC’s over the last 12 months.

ORMP's P/E Growth Rating (50) in the Pharmaceuticals Other industry is somewhat better than the same rating for IMUC (100) in the Biotechnology industry. This means that ORMP’s stock grew somewhat faster than IMUC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMUCORMP
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 13 days ago
60%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 25 days ago
90%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
IMUC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAWW0.70N/A
N/A
CCA Industries, Inc.
HRIBF61.03N/A
N/A
Horiba Ltd.
MGRUF4.23N/A
N/A
Morguard Real Estate Investment Trust
WPPGF6.09N/A
N/A
WPP PLC
GRWLF15.45N/A
N/A
Great West Lifeco, Inc.

IMUC and

Correlation & Price change

A.I.dvisor tells us that IMUC and GRCE have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMUC and GRCE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMUC
1D Price
Change %
IMUC100%
N/A
GRCE - IMUC
7%
Poorly correlated
-3.75%
TNXP - IMUC
6%
Poorly correlated
+9.24%
SRPT - IMUC
5%
Poorly correlated
-7.38%
ORMP - IMUC
5%
Poorly correlated
N/A
PTCT - IMUC
4%
Poorly correlated
-3.41%
More

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BTAI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BTAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
N/A
BTAI - ORMP
44%
Loosely correlated
N/A
INO - ORMP
44%
Loosely correlated
-2.65%
MBIO - ORMP
44%
Loosely correlated
-5.91%
VERV - ORMP
44%
Loosely correlated
N/A
ZNTL - ORMP
43%
Loosely correlated
N/A
More